Abdera Therapeutics
Will Chan is an experienced operations specialist with a strong background in inventory management, logistics, and quality control within the life sciences and produce industries. Currently serving as an Operations Specialist at Abdera Therapeutics since September 2022, Will adeptly manages daily lab operations, enhances lab efficiency, and fosters interdepartmental communication. Prior roles include Material Handler II at Zymeworks Inc., where responsibilities included managing temperature-sensitive biological shipments and resolving customs issues, and Operations Coordinator at Star Produce, where inventory control and logistics coordination were key duties. Will's educational background includes studies at UBC Sander School of Business and a Criminology Diploma from Douglas College, further complementing professional expertise.
Abdera Therapeutics
1 followers
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers. Its targeted radiotherapies utilize purpose-built vectors to specifically target high-energy radio-isotopes to tumors and metastatic cancer lesions. This new class of drugs holds tremendous untapped therapeuticand commercial potential, and has generated over $10B in recent M&A, financings, and product launches – and are expected to comprise 70% of the $30B nuclear medicine market by 2030.It was launched by adMare BioInnovations, Canada’s global life sciences venture, in partnership with industry leaders AbCellera, and some of the country’s most successful scientist entrepreneurs.